Fulgent Genetics (FLGT) Non-Current Assets (2015 - 2026)

Fulgent Genetics has reported Non-Current Assets for 12 years, with the latest figure at $634.5 million in Q2 2026.

• Quarterly Non-Current Assets fell 17.72% year-over-year to $634.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.7 billion (down 19.55% YoY) and the FY2025 annual result came in at $663.0 million, down 23.47% from the prior year.
• Non-Current Assets eased to $634.5 million in Q2 2026 per FLGT's latest filing, from $677.3 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $907.2 million in Q3 2024 and troughed at $634.5 million in Q2 2026.
• A 5-year average of $766.9 million and a median of $778.8 million in 2022 frame the typical range for Non-Current Assets.
• The sharpest annual moves came in 2022 and 2025: Non-Current Assets soared 105.99% in 2022, then dropped 23.47% in 2025.
• Over 5 years, Non-Current Assets stood at $758.2 million in 2022, then slipped by 4.05% to $727.5 million in 2023, then rose by 19.09% to $866.4 million in 2024, then decreased by 23.47% to $663.0 million in 2025, then slipped by 4.31% to $634.5 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $634.5 million, $677.3 million, and $663.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.